BRAIN Biotech AG
XETRA:BNN
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
BRAIN Biotech AG Competitors
Country | DE |
Market Cap | 74.3m EUR |
ROE |
-32%
|
Country | JP |
Market Cap | 13.2T JPY |
ROE |
13%
|
Country | US |
Market Cap | 88.3B USD |
ROE |
70%
|
Country | US |
Market Cap | 66.1B USD |
ROE |
18%
|
Country | CH |
Market Cap | 42.4B CHF |
ROE |
20%
|
Country | CH |
Market Cap | 37B CHF |
ROE |
22%
|
Country | CN |
Market Cap | 250.4B CNY |
ROE |
19%
|
Country | US |
Market Cap | 34B USD |
ROE |
18%
|
Country | US |
Market Cap | 32.9B USD |
ROE |
2%
|
Country | IN |
Market Cap | 2.7T INR |
ROE |
35%
|
Country | CH |
Market Cap | 27.9B EUR |
ROE |
13%
|
ROE Distribution
ROE Distribution
Chemicals Industry
Profitability Report
View the profitability report to see the full profitability analysis for BRAIN Biotech AG.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on BRAIN Biotech AG's most recent financial statements, the company has ROE of -32.2%.